Michawl Infusion Therapy is categorized under Rehabilitation Center, Outpatient Treatment in Saint Charles, MO and active since 2010.
Michawl Infusion Therapy was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Bowen at the company’s single location by writing to 330 Ameristar Boulevard, Saint Charles, Missouri MO 63301 or by phoning (314) 506-6146. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Michawl Infusion Therapy |
| Contact Person: | Jeffrey Bowen |
| Address: | 330 Ameristar Boulevard, Saint Charles, Missouri 63301 |
| Phone Number: | (314) 506-6146 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rehabilitation Center, Outpatient Treatment |
| SIC Code: | 8093 |
| NAICS Code: | 621498 |
| Share This Business: |
Michawl Infusion Therapy was started in 2010 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jeffrey Bowen for inquiries that concern Michawl Infusion Therapy by calling the company number (314) 506-6146, as your correspondence is most welcome. Additionally, the physical location of the single location of Michawl Infusion Therapy can be found at the coordinates 38.769546,-90.4905 as well as the street address 330 Ameristar Boulevard in Saint Charles, Missouri 63301.
For its online presence, you may visit Michawl Infusion Therapy’s website at and engage with its social media outlets through on Twitter and on Facebook.